EUVIMEDEUVIMED entdecken
Crossref

Trajectory of Hematoma Growth and Functional Recovery after Intracerebral Hemorrhage: A Latent Class Analysis of Blood Pressure in Acute Stroke Collaboration Data

Menglu Ouyang, Shoujiang You, Tom J Moullaali, Candice Delcourt, Else Charlotte Sandset, Lisa Woodhouse, Zhe Kang Law, Hisatomi Arima, Ken Butcher, Leon Stephen Edwards, Salil Gupta, Wen Jiang und 12 weitere

Cerebrovascular Diseases · 2025

DOI: 10.1159/000547678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases, 2025. Verfasst von Menglu Ouyang und 23 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Kensington, New South Wales, Australia. Hauptthemen laut MEDLINE: Hematoma, Blood Pressure, Antihypertensive Agents, Cerebral Hemorrhage. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Moderate blood pressure (BP) reduction reduces hematoma growth, but this has not been shown to translate into improved functional recovery after intracerebral hemorrhage (ICH). This study aimed to define patient profiles according to hematoma growth and functional recovery patterns, and explore the prognostic factors of the patterns.

Methods

Analysis of the Blood Pressure in Acute Stroke Collaboration (BASC) dataset involved randomized controlled trials of early BP lowering in acute ICH. Latent class analysis was used to identify patient profiles by hematoma volume change from baseline to 24 h on outcome trajectories. Clinical outcomes include functional outcomes measured according to modified Rankin Scale (mRS) and serious adverse events at follow-up (usually 90 days). Generalized linear mixed models were used with adjustment of source trial as a random effect for clustering to identify the prognostic factors.

Results

Among 6,221 participants from BASC, 2,450 patients (mean age 64.1 + 13.1 years, female 36.7%) were included. Baseline hematoma volumes (mL) were 6.8, 13.2, 27.1, and 59.2, respectively, for each class identified by patient profiles: no growth with favorable outcome (52.1%, median growth 0.2 [IQR −0.4 to 1.1] mL, median mRS 2 [IQR 1 to 2]), mild growth with disability (32.6%, 0.8 [−0.8 to 4.6] mL, mRS 4 [4 to 5]), moderate growth with death or disability (13.2%, 11.2 [4.9 to 27.0] mL, mRS 4 [3 to 6]), and large growth with death (2.1%, 35.2 [12.8 to 81.2] mL, mRS 6 [6 to 6]). Patients with moderate growth were younger and more likely to undergo neurosurgery than those in the mild or large growth groups. Baseline hematoma volume was the only significant factor associated with all the hematoma pattern groups.

Conclusions

Patients with moderate growth were younger and more likely to receive neurosurgery than those in the mild or large growth groups. Baseline hematoma volume is the most important factor for hematoma growth and clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HematomaBlood PressureAntihypertensive AgentsCerebral HemorrhageHemorrhagic StrokeHumansRecovery of FunctionFemaleTime FactorsTreatment OutcomeAgedFunctional StatusDisability EvaluationMaleRisk FactorsMiddle AgedLatent Class AnalysisDatabases, FactualRandomized Controlled Trials as TopicDisease Progression

Stichwörter der Autor:innen

Acute strokeBlood pressure treatmentHematoma expansionIntracerebral hemorrhageLatent class

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Kensington, New South Wales, Australia.
  • Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Centre for Clinical Brain Sciences, University of Edinburgh, University of Edinburgh, Edinburgh, UK.
  • Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Research and Development Department, The Norwegian Air Ambulance Foundation, Oslo, Norway.

Zitieren

APA

Ouyang, M., You, S., Moullaali, T. J., Delcourt, C., Sandset, E. C., Woodhouse, L., Law, Z. K., Arima, H., Butcher, K., Edwards, L. S., Gupta, S., Jiang, W., Koch, S., Potter, J., Qureshi, A. I., Robinson, T. G., Al-Shahi Salman, R., Saver, J. L., Sprigg, N., …, & Wang, X. (2025). Trajectory of Hematoma Growth and Functional Recovery after Intracerebral Hemorrhage: A Latent Class Analysis of Blood Pressure in Acute Stroke Collaboration Data. Cerebrovascular Diseases. https://doi.org/10.1159/000547678

Vancouver

Ouyang M, You S, Moullaali TJ, Delcourt C, Sandset EC, Woodhouse L, et al. Trajectory of Hematoma Growth and Functional Recovery after Intracerebral Hemorrhage: A Latent Class Analysis of Blood Pressure in Acute Stroke Collaboration Data. Cerebrovascular Diseases. 2025. doi:10.1159/000547678

BibTeX
@article{Ouyang2025,
  author = {Ouyang, Menglu and You, Shoujiang and Moullaali, Tom J and Delcourt, Candice and Sandset, Else Charlotte and Woodhouse, Lisa and Law, Zhe Kang and Arima, Hisatomi and Butcher, Ken and Edwards, Leon Stephen and Gupta, Salil and Jiang, Wen and Koch, Sebastian and Potter, John and Qureshi, Adnan I and Robinson, Thompson G and Al-Shahi Salman, Rustam and Saver, Jeffrey L and Sprigg, Nikola and Wardlaw, Joanna and Anderson, Craig S and Bath, Philip M and Chalmers, John Philip and Wang, Xia},
  title = {Trajectory of Hematoma Growth and Functional Recovery after Intracerebral Hemorrhage: A Latent Class Analysis of Blood Pressure in Acute Stroke Collaboration Data},
  journal = {Cerebrovascular Diseases},
  year = {2025},
  doi = {10.1159/000547678}
}
Kostenlos starten →